ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ORCHIDPHAR announcements Orchid Pharma Limited announcements and dividends declared NSE

Orchid Pharma Limited Complete list of announcements declared & dividend announcements by Orchid Pharma Limited ORCHIDPHAR

Orchid Pharma Limited ORCHIDPHAR listed on NSE and deals in

Announcements and dividends declared by Orchid Pharma Limited ORCHIDPHAR

Breakdown Stocks: How to trade Orchid Pharma, Everest Industries and Jai Corp that hit a 52-week low?
Indian markets rebounded strongly on Tuesday, with the Sensex surging over 1,000 points and Nifty crossing 22,500, led by gains in capital goods, telecom, and oil & gas sectors.
Announcement as on 08 April 2025

Stocks in news: Cyient, Waaree Energies, BSE, Tata Technologies, Orchid Pharma
Shares of IREDA and Tata Technologies will be in focus after an NSE release confirmed the inclusion of these in the futures and options segment from February 28.
Announcement as on 20 February 2025

Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
Orchid Pharma said that it has partnered with Cipla to ensure widespread and rapid distribution of the company's new drug- Cefepime-Enmetazobactam across India.
Announcement as on 29 June 2024

Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
Orchid Pharma announced the launch of its new drug - Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.
Announcement as on 28 June 2024

Debt-free Orchid Pharma charts out growth plan
Orchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch, and mergers for sustainable growth and reduced import reliance.
Announcement as on 24 April 2024

Announcements by Orchid Pharma Limited first page | Next page |

ORCHIDPHAR Orchid Pharma Limited current price & indicator signals

Moving Averages for Orchid Pharma Limited

  • 5Day Average: 6.76
  • 12Day Average: 7.28
  • 20Day Average: 7.41
  • 50Day Average: 9.55
  • 100Day Average: 12.93
  • 150Day Average: 14.9
  • 200Day Average: 15.83

ORCHIDPHAR Indicators & signals

Indicator MACD (12,26,9)

7.13, 7.93, -0.81
Indicator MACD is in negative zone

Indicator ADX (14)

53.33, 11.11, 36.51
Indicator ADX is indicating that momentum is still strong.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 42
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ORCHIDPHAR Orchid Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Fri Oct 2018 5.60 5.50 to 5.70 -21.13% 0.4 times
08 Fri Jun 2018 7.10 6.65 to 7.20 2.16% 0.79 times
07 Thu Jun 2018 6.95 6.80 to 7.15 -2.8% 1.54 times
06 Wed Jun 2018 7.15 6.80 to 7.25 2.14% 0.76 times
05 Tue Jun 2018 7.00 7.00 to 7.50 -4.76% 1.38 times
04 Mon Jun 2018 7.35 7.30 to 7.90 -3.92% 0.54 times
01 Fri Jun 2018 7.65 7.25 to 7.90 0.66% 0.46 times
31 Thu May 2018 7.60 7.50 to 8.20 -3.18% 0.56 times
30 Wed May 2018 7.85 7.75 to 8.10 -1.26% 0.32 times
29 Tue May 2018 7.95 7.40 to 8.10 2.58% 2.64 times
28 Mon May 2018 7.75 7.65 to 7.80 4.03% 1 times
25 Fri May 2018 7.45 7.20 to 7.60 2.76% 0.48 times

Videos related to: ORCHIDPHAR announcements Orchid Pharma Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

ORCHIDPHAR announcements Orchid Pharma Limited announcements and dividends declared NSE

 

Back to top